Loading company…
Riskpilot
← Back to search
Sign in
Get full access
SVEA AB
AB
Active
Org 5594214891
Fågelbacksgatan 9 B
Hospital activities · NACE 8610
Est. 2023
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 114K
-84% vs 2024
EBITDA margin
51.1%
-90% vs 2024
Equity ratio
19.9%
Financial strength
Net profit 2025
SEK 18K
-95% vs 2024
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
SEK 114K
-84%
EBITDA
SEK 58K
-90%
Net profit
SEK 18K
-95%
Total assets
SEK 2M
+0%
Equity
SEK 397K
+5%
Employees
1
—
Company information
Legal name
SVEA AB
Org number
5594214891
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
9 februari 2023
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsultverksamhet inom sjukvård på vårdcentral och sjukhus. Företaget ska också bedriva verksamhet inom estetiska behandlingar.
Contact
Address
Fågelbacksgatan 9 B
Email
wazhma_stanikzai@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Hospital activities
Companies in Malmö
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2024
0M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
730
114
Staff expenses
−5
−8
EBITDA
602
58
Depreciation & amort.
−9
−17
EBIT
593
41
Net financials
1
−9
Profit before tax
446
24
Tax
−92
−5
Net profit
354
18
Balance sheet
SEK thousands
Item
2024
2025
Total assets
1 999
1 999
Equity
379
397
Long-term debt
—
—
Short-term debt
1 472
1 445
Total debt
1 472
1 445
Financial ratios
5-year trend
EBITDA margin
51.1%
This company
15.8%
Market median
+223% vs market
2024
2025
Equity ratio
19.9%
This company
38.2%
Market median
-48% vs market
2024
2025
Return on equity
4.7%
This company
18.4%
Market median
-74% vs market
2024
2025
Net profit margin
16.2%
This company
8.1%
Market median
+100% vs market
2024
2025
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
2024
2025
Debt / equity
4.03×
This company
0.62×
Market median
-550% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-02-09 – 2024-04-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
HS
Huma Stanagzai
Deputy Board Member
2023
WS
Wazhma Stanikzai
Board of Directors
2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Royal Medical Care Sweden AB
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Royal Medical Care Sweden AB
SVEA AB
(this company)
Board network connections
Board members of SVEA AB also hold positions in
0
other companies.
Person
Role here
Other companies
Huma Stanagzai
Deputy Board Member
0 companies
Wazhma Stanikzai
Board of Directors
0 companies